Our finding that CXCR4 activated PLCγ2 signaling in B-ALL cells is consistent with the finding that PLCγ2-deficient B cells exhibited impaired SDF-1-signaling16. This evidence concerns the gene CXCL12 and precursor B-cell acute lymphoblastic leukemia.